Biogen Inc. (BIIB): Cash & Equivalents
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$2.91B
As of 2019-12-31
+7.8%
3-year compound annual growth
+19.3%
5-year compound annual growth
+17.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2019-12-31 | $2.91B | +137.9% | 2020-02-06, Balance as of period end |
| 2018-12-31 | $1.22B | -22.2% | 2020-02-06, Balance as of period end |
| 2017-12-31 | $1.57B | -32.4% | 2020-02-06, Balance as of period end |
| 2016-12-31 | $2.33B | +77.9% | 2019-02-06, Balance as of period end |
| 2015-12-31 | $1.31B | +8.6% | 2018-02-01, Balance as of period end |
| 2014-12-31 | $1.20B | +100.0% | 2017-02-02, Balance as of period end |
| 2013-12-31 | $602.60M | +5.6% | 2016-02-03, Balance as of period end |
| 2012-12-31 | $570.72M | +10.9% | 2015-02-04, Balance as of period end |
| 2011-12-31 | $514.54M | -32.3% | 2014-02-06, Balance as of period end |
| 2010-12-31 | $759.60M | +30.5% | 2013-02-05, Balance as of period end |
| 2009-12-31 | $581.89M | -6.5% | 2012-02-03, Balance as of period end |
| 2008-12-31 | $622.38M | -5.7% | 2011-02-04, Balance as of period end |
| 2007-12-31 | $659.66M | n/a | 2010-02-09, Balance as of period end |